Adma Biologics (ADMA) Gross Profit (2011 - 2026)
Adma Biologics (ADMA) posted Gross Profit of $99.92 million for Q3 2026, up 32.1% from $75.63 million a year earlier and up 15.8% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Gross Profit (2011 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Gross Profit at Adma Biologics was $355.76 million, up 33.1% year-over-year; for FY2025, it came in at $292.77 million, up 33.3% from FY2024.
- Annual Gross Profit has increased for three consecutive years.
- In prior years, Adma Biologics' Gross Profit was $219.55 million in FY2024 (+146.8%), $88.94 million in FY2023 (+152.2%), $35.27 million in FY2022 and $1.17 million in FY2021.
- The Q3 2026 figure stands as the highest quarterly Gross Profit in data going back to Q4 2011.
- On a year-over-year basis, Gross Profit has increased in each of the last 16 quarters, with growth averaging 42.1% over the last eight quarters.
- Over the past five years, the year-over-year growth in Gross Profit ranged from 17.0% (Q2 2025) to 350.9% (Q1 2023).
- According to Business Quant data, Gross Profit for the three prior quarters was $86.28 million (Q2 2026), $80.75 million (Q1 2026) and $88.82 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 99.92 Mn |
| Jun 30, 2026 | 86.28 Mn |
| Mar 31, 2026 | 80.75 Mn |
| Dec 31, 2025 | 88.82 Mn |
| Sep 30, 2025 | 75.63 Mn |
| Jun 30, 2025 | 67.23 Mn |
| Mar 31, 2025 | 61.10 Mn |
| Dec 31, 2024 | 63.33 Mn |
| Sep 30, 2024 | 59.66 Mn |
| Jun 30, 2024 | 57.45 Mn |
| Mar 31, 2024 | 39.11 Mn |
| Dec 31, 2023 | 31.09 Mn |
| Sep 30, 2023 | 24.65 Mn |
| Jun 30, 2023 | 16.69 Mn |
| Mar 31, 2023 | 16.51 Mn |
| Dec 31, 2022 | 14.18 Mn |
| Sep 30, 2022 | 9.66 Mn |
| Jun 30, 2022 | 7.77 Mn |
| Mar 31, 2022 | 3.66 Mn |
| Dec 31, 2021 | 3.51 Mn |
API Access
Adma Biologics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();